Coherus BioSciences Inc (NAS:CHRS)
$ 1.76 -0.06 (-3.3%) Market Cap: 201.92 Mil Enterprise Value: 429.62 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Coherus BioSciences Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 08:05PM GMT
Release Date Price: $6.35 (-0.31%)
Unidentified Analyst

Good afternoon, everyone. So continuing the afternoon session for the day, we have with us the management from Coherus. And we have Dennis Lanfear, CEO; and Rosh Dias, CMO; and of course, Paul Reider Chief Commercial Officer. Dennis, Paul and Rosh, thanks so much for taking your time to join us today.

Dennis M. Lanfear
Coherus BioSciences, Inc. - Chairman, President & CEO

Thank you. Thank you very much, and thank you once again for your invitation. It's nice to be here in Miami.

Unidentified Analyst

Of course, absolutely. (inaudible) meetings. So since you reported a couple of weeks ago, why don't we up with recapping some of the key highlights from the earnings call and [risk focus before we go to Q&A].

Dennis M. Lanfear
Coherus BioSciences, Inc. - Chairman, President & CEO

Sure. I'd be happy to do that. That's in 2022, we made substantial progress on our overarching strategy with respect to the development of our other, our IO portfolio with sales

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot